Stephen S. Ferguson PhD

Stephen S. Ferguson is a scientist in the Molecular Toxicology and Genomics Group within the Biomolecular Screening Branch (BSB) of the National Toxicology Program (NTP). Ferguson is also adjunct faculty in the National Toxicology Program Laboratories (NTPL). In his current role, Ferguson leads NTP efforts to develop and apply more physiologically-relevant in vitro toxicology screening models as part of Phase III of the Tox21 program.

Prior to joining NTP, Ferguson led the ADME/Tox research program at Life Technologies (formerly CellzDirect) where his group investigated and developed in vitro tools for hepatic biology, drug clearance, and drug-drug interaction pathway research. Ferguson also has a background in contract research management serving for multiple years as a Study Director on numerous non-clinical drug metabolism and pharmacokinetics (DMPK) studies for pharmaceutical research.

Ferguson obtained his B.S. in Chemistry from North Carolina State University followed by a Ph.D. in Chemistry (Bioinorganic focus) with a minor in Biotechnology from North Carolina State University.